Investment Firms in Claymont, Delaware, United States
Situated within the broader Mid-Atlantic biotechnology corridor, this area benefits from proximity to major research institutions and pharmaceutical hubs. Its venture activity is predominantly focused on early-stage funding within the healthcare and life sciences sectors. The local investment landscape reflects a specialized, research-driven ecosystem that has developed more formally in recent years.
Claymont, Delaware, United States's investment landscape is shaped by Healthcare, with 100% of its 1 investment firms focused on this sector. The most active by portfolio size are MBX Capital.
Healthcare dominates the investment landscape in Claymont, with 100% of investment firms focused on this sector.
Last updated: 13 March 2026
Investment Firms
1
Total Investments
5
Top Sector
Healthcare
Top Stage
Series A
Top Investment Sectors in Claymont
The most popular sector focus among Claymont investment firms is Healthcare, with 1 investment firm (100%) investing in the space. This is followed by Biotech & Life Sciences (1).
Investment Stages in Claymont
Claymont investment firms are most active at the Series A stage (1 investment firm). This is followed by Seed (1), Series B (1).
